CINECA IRIS Institutional Research Information System

CARROZZI, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.567
AS - Asia 11.264
EU - Europa 8.450
SA - Sud America 2.204
AF - Africa 699
OC - Oceania 54
Continente sconosciuto - Info sul continente non disponibili 4
Totale 38.242
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.101
IT - Italia 4.231
SG - Singapore 3.574
CN - Cina 2.391
HK - Hong Kong 2.176
BR - Brasile 1.779
VN - Vietnam 1.206
SE - Svezia 818
DE - Germania 604
BG - Bulgaria 589
FR - Francia 499
IN - India 380
GB - Regno Unito 372
RU - Federazione Russa 304
FI - Finlandia 290
TR - Turchia 281
CI - Costa d'Avorio 280
JP - Giappone 264
CA - Canada 243
KR - Corea 159
AT - Austria 139
BD - Bangladesh 138
AR - Argentina 135
NL - Olanda 126
IQ - Iraq 101
MX - Messico 91
UA - Ucraina 91
ID - Indonesia 90
ZA - Sudafrica 77
CH - Svizzera 76
PK - Pakistan 76
SN - Senegal 74
EC - Ecuador 64
PL - Polonia 62
CO - Colombia 60
SA - Arabia Saudita 56
VE - Venezuela 51
NG - Nigeria 50
MA - Marocco 49
AU - Australia 46
PH - Filippine 43
UZ - Uzbekistan 43
ES - Italia 41
PY - Paraguay 34
IE - Irlanda 32
AE - Emirati Arabi Uniti 30
TN - Tunisia 30
BE - Belgio 29
TT - Trinidad e Tobago 28
EG - Egitto 27
KE - Kenya 25
IR - Iran 24
MY - Malesia 24
JO - Giordania 22
TH - Thailandia 22
CL - Cile 21
UY - Uruguay 21
PE - Perù 20
JM - Giamaica 19
KZ - Kazakistan 19
PT - Portogallo 18
BJ - Benin 17
DZ - Algeria 17
NP - Nepal 17
RO - Romania 15
CZ - Repubblica Ceca 14
GR - Grecia 14
BO - Bolivia 13
CR - Costa Rica 13
DK - Danimarca 13
ET - Etiopia 13
IL - Israele 13
TW - Taiwan 13
LT - Lituania 12
HN - Honduras 11
HU - Ungheria 11
LB - Libano 11
OM - Oman 11
AL - Albania 10
BB - Barbados 9
PA - Panama 9
PS - Palestinian Territory 9
DO - Repubblica Dominicana 8
AM - Armenia 7
AZ - Azerbaigian 7
BH - Bahrain 7
KH - Cambogia 7
NZ - Nuova Zelanda 7
SV - El Salvador 7
GT - Guatemala 6
KW - Kuwait 6
LK - Sri Lanka 6
SY - Repubblica araba siriana 6
KG - Kirghizistan 5
LI - Liechtenstein 5
MD - Moldavia 5
NI - Nicaragua 5
NO - Norvegia 5
TZ - Tanzania 5
BA - Bosnia-Erzegovina 4
Totale 38.138
Salva come PNG Salva come JPEG
Città #
Hong Kong 2.139
Ashburn 2.037
Singapore 1.927
Dallas 1.164
San Jose 1.099
Santa Clara 1.020
Fairfield 744
Shanghai 705
Houston 703
Woodbridge 644
Chandler 601
Sofia 585
New York 508
Boardman 440
Ann Arbor 437
Beijing 424
Milan 405
Ho Chi Minh City 373
Seattle 352
Florence 347
Wilmington 341
Princeton 332
Los Angeles 308
Lawrence 292
Abidjan 278
Lauterbourg 275
Pisa 272
Cambridge 271
Hanoi 260
Tokyo 245
Rome 226
Hefei 223
Medford 211
Munich 201
Istanbul 172
Council Bluffs 154
Frankfurt am Main 152
Seoul 142
São Paulo 139
Redondo Beach 132
Buffalo 115
Helsinki 113
San Diego 113
Ottawa 112
Vienna 104
Chicago 91
London 89
Des Moines 85
Ogden 83
Jacksonville 81
Genoa 78
Nanjing 77
Dakar 74
Bremen 69
Turku 67
Naples 63
Lucca 57
Dong Ket 52
Belo Horizonte 51
Serra 51
Dearborn 50
Turin 50
Warsaw 48
Da Nang 46
Nuremberg 46
Bologna 45
Orem 45
Rio de Janeiro 44
Izmir 40
Palermo 40
Pune 40
Baghdad 38
Washington 38
Johannesburg 37
Tashkent 37
Düsseldorf 36
Livorno 36
Atlanta 35
Haiphong 35
Redwood City 35
San Francisco 35
Bari 34
Catania 34
Denver 34
Lancaster 34
Bern 33
Amsterdam 32
Brooklyn 32
Norwalk 32
Brasília 31
Mumbai 31
Dhaka 30
Phoenix 30
Guangzhou 29
Montreal 29
Chennai 28
Dublin 28
Verona 28
Toronto 27
Cascina 26
Totale 24.343
Salva come PNG Salva come JPEG
Nome #
Malattie respiratorie da droga - Ma.Re.D 1.505
null 346
A narrative review of epidemiology and prevention of lung cancer: sex/gender differences? 262
Integrated environmental and clinical surveillance for the prevention of acute respiratory infections in closed settings and vulnerable communities: school, prison and nursing home (Stell-ARI Project) 261
Idiopathic interstitial pneumonias: do HRCT criteria established by ATS/ERS/JRS/ALAT in 2011 predict disease progression and prognosis? 246
Usefulness of a compendium of respiratory standard questionnaires for adults (CORSQ) 246
Percorso di follow-up clinico, funzionale e radiologico dei pazienti dimessi con diagnosi di COVID-19 dall’Azienda Ospedaliero-Universitaria Pisana (AOUP) - Metodologia e arruolamento preliminare 237
C-C motive chemokine ligand 2 and thromboinflammation in COVID-19-associated pneumonia: A retrospective study 229
LHF Connect: A DIY telepresence robot against COVID-19 228
Epidemiologia ed effetti sulla salute del fumo di tabacco 227
Standardized Clinical, Functional, and Radiological Pulmonary Follow-Up in Patients Discharged with Diagnosis of COVID-19 From an Italian Hospital - Preliminary Data 218
Investigating Promising Point-of-Care Diagnostics in Pleural Effusion: Assessment of Bedside Glucometer Accuracy for Pleural Fluid Glucose Versus Standard Laboratory and Blood Gas Analyser Methods 215
Reduction of risk of dying from tobacco-related diseases after quitting smoking in Italy 211
Is There a Crucial Link Between Vitamin D Status and Inflammatory Response in Patients With COVID-19? 211
Integrated environmental and clinical surveillance of viral acute respiratory infections in close communities: opportunities and challenges 209
Appendix 3: Compendium of respiratory standard questionnaires for adults (CORSQ) 208
Patterns of Long COVID Symptoms: A Multi-Center Cross Sectional Study 197
null 194
Impact of long-term exposure to cigarette smoking on skin microvascular function 194
Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial 193
Screen-detected multiple primary lung cancers in the ITALUNG trial 193
D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study 186
Epidemiologia della broncopneumopatia cronico-ostruttiva: fattori di rischio ambientali ed occupazionali [Epidemiology of the chronic obstructive pulmonary disease: Environmental and occupational risk factors] 182
Venous Thromboembolism in Cancer: Frequently Asked Questions When Guidelines are Inconclusive 181
Basi fisiopatologiche, diagnosi e trattamento del tabagismo 181
Inclusion of peak expiratory flow for selection of the 'best' forced vital capacity manoeuvre 181
Multimodal lung cancer screening using the ITALUNG Biomarker Panel and Low Dose Computed Tomography. Results of the ITALUNG biomarker study 181
Prevalence of respiratory symptoms in an unpolluted area of northern Italy 177
Idiopathic interstitial pneumonias: do HRCT criteria established by ATS/ERS/JRS/ALAT in 2011 predict disease progression and prognosis? 177
Application of a pharmacokinetic/pharmacogenetic approach to assess the nicotine metabolic profile of smokers in the real-life setting 175
Respiratory symptoms/diseases prevalence is still increasing: A 25-yr population study 173
Fattori individuali e ambientali di rischio respiratorio in soggetti vulnerabili che vivono in comunità chiuse (RSA e carcere): dati preliminari dello studio StellARI 172
Chromosome aberrations in humans in relation to site of residence. 172
L'epidemiologia della broncopneumopatia cronica ostruttiva 170
Prolonged higher dose methylprednisolone versus conventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS) 165
Prescriptive adherence to GINA guidelines and asthma control: An Italian cross sectional study in general practice 165
Definition, epidemiology and natural history of COPD 164
RItA: The Italian severe/uncontrolled asthma registry 163
I centri antifumo in Italia e il progetto 6elle 163
Integrated environmental and clinical surveillance for the prevention of acute respiratory infections (ARIs) in indoor environments and vulnerable communities (Stell-ARI): Protocol 162
Surgery for giant bullae in patients with and without COPD. 162
Smooth reference equations for slow vital capacity and flow-volume curve indexes 160
ARDS da prolasso mitralico acuto in assuntore di cocaina 160
Family history for chronic lung diseases and epidemiological determinants of COPD in three European countries 159
L’attività dei Centri Antifumo italiani tra problematiche e aree da potenziare: i risultati di un’indagine svolta attraverso un questionario on-line 159
A diagnostic strategy for pulmonary embolism based on standardised pretest probability and perfusion lung scanning: a management study 157
International association for the study of lung cancer computed tomography screening workshop 2011 report 156
Reference equations for spirometry from a general population sample in central Italy 155
Serum antibodies to benzo(a)pyrene diol epoxide-DNA adducts in the general population: effects of air pollution, tobacco smoking, and family history of lung diseases 154
Life gain in Italian smokers who quit 151
Comparison of algorithms for determining the end-point of the forced vital capacity maneuver 150
Questionnaires, spirometry and PEF monitoring in epidemiological studies on elderly respiratory patients 149
Fumo di sigaretta in gravidanza: studio osservazionale prospettico in tre città della Toscana [Cigarette smoking in pregnancy: observational prospective study in three towns of Tuscany Region (Central Italy)] 148
Evaluation of severity of diffuse emphysema in patients with giant bullae before bullectomy 147
COPD management according to old and new GOLD guidelines: An observational study with Italian general practitioners 147
A diagnostic strategy for pulmonary embolism based on standardized pretest probability and perfusion lung scanning ? A management study 146
Decreased cardiovascular mortality in the ITALUNG lung cancer screening trial: Analysis of underlying factors 145
18-yr cumulative incidence of respiratory/allergic symptoms/diseases and risk factors in the Pisa epidemiological study 145
Smoking Cessation in the ITALUNG Lung Cancer Screening: what does “teachable moment” mean? 144
Pulmonary phenotypes and COVID-19 evolution patterns during the first year of the pandemic 143
Surgery for giant bullae in patients with and without COPD 143
Respiratory symptoms/diseases, impaired lung function, and drug use in two Italian general population samples 143
Distribution of bronchial responsiveness in a general population: effect of sex, age, smoking, and level of pulmonary function 143
Quantitative CT Texture Analysis of COVID-19 Hospitalized Patients during 3–24-Month Follow-Up and Correlation with Functional Parameters 142
Radionuclide imaging in preoperative evaluation of bullous emphysema 142
Active and passive tobacco smoking 142
Molecular profile in body fluids in subjects enrolled in a randomised trial for lung cancer screening: Perspectives of integrated strategies for early diagnosis 142
Nicotine dependence and psychological distress: outcomes and clinical implications in smoking cessation 141
Inferior vena cava filters: Concept review and summary of current guidelines 139
Influence of bulla volume on postbullectomy outcome 139
Depressive, anxious, withdrawal symptoms, and craving as possible predictors of abstinence maintenance in smokers attending a 12-week quitting program 139
null 138
Percentiles of Inspiratory Capacity in Healthy Nonsmokers: A Pilot Study 137
Work-related asthma in a sample of subjects with established asthma 136
Urban residence is associated with bronchial hyper-responsiveness in Italian general population samples 136
Pirfenidone for Idiopathic Pulmonary Fibrosis and Beyond 136
Estimated pulse wave velocity improves risk stratification for all-cause mortality in patients with COVID-19 135
Retrospective Study on the Features and Outcomes of a Tuscany COVID-19 Hospitalized Patients Cohort: Preliminary Results 133
Early and late follow-up of pulmonary embolism 133
Bronchitic symptoms in Italy and Sweden - Prevalence and risk factors 133
Long-term lung ultrasound follow-up in patients after COVID-19 pneumonia hospitalization: A prospective comparative study with chest computed tomography 132
Serum antibodies to benzo[a]pyrene diolepoxide-DNA adducts in the general population: effects of air pollution, tobacco smoking, and family history of lung diseases 132
Multy-symptom asthma (msa) as indication of healthcare utilization burden (hub) in a cohort of Italian young asthmatic subjects 132
Prescriptive appropriateness using the new GOLD guidelines in the COMODHES study with Italian general practitioners 132
Four-year results of low-dose CT screening and nodule management in the ITALUNG trial. 132
Respiratory symptoms/diseases and lifetime cumulative exposure to environmental tobacco smoke (ETS) in never smoker Italian women (SEASD Study) 131
Weight gain after smoking cessation 131
Should perfusion scintigraphy be done to follow patients with acute PE? If so, when? 131
Prospective study of a standardized questionnaire to improve clinical estimate of pulmonary embolism 130
Five-year follow-up of pulmonary embolism under anticoaugulation: The PISA-PEET (Pulmonary Embolism Extension Therapy) study 130
Smoking reduction in smokers compliant to a smoking cessation trial with nicotine patch 130
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study 130
Short term longitudinal evaluation of smoking-related emphysema: analisys from Italung-CT Study 129
Changes in obesity status and lung function decline in a general population sample 129
[Serum IgE, atopy, bronchial reactivity: details on female patients] 128
Bullous emphysema: anuual decline of FEV1 after bullectomy 128
Integrating the care of the complex COPD patient 128
Imaging medico-nucleare nella valutazione preoperatoria dell'enfisema nei pazienti con bolle giganti 127
A randomized placebo-controlled trial of varenicline for smoking cessation allowing flexible quit dates 127
Nicotine Metabolite Ratio in Smokers: A Real World Experience 125
Totale 17.723
Salva come PNG Salva come JPEG
Categoria #
all - tutte 130.187
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 130.187
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.888 60 128 49 106 505 470 240 138 164 79 226 723
2022/20233.332 476 289 255 221 261 358 62 195 702 84 268 161
2023/20243.331 254 228 345 187 409 642 203 243 106 131 181 402
2024/202510.743 241 459 241 492 810 828 977 567 1.223 1.499 1.062 2.344
2025/202612.839 586 1.582 1.772 1.593 1.192 962 1.765 639 819 1.128 473 328
2026/2027177 177 0 0 0 0 0 0 0 0 0 0 0
Totale 39.131